Company: INVUP
Filing Date: 2025-08-13
Form Type: 10-Q
Source: 0001493152-25-011912
Chunk: 97

Company: Investview, Inc.
Filing Date: 2025-08-13
Form: 10-Q
Item: Part I, Item 8
Chunk 97
---
,041 

[1]On
                                            April 27, 2020, we received proceeds of $1,300,000 from DBR Capital, LLC (“DBR Capital”),
                                            an entity controlled by a member of our Board of Directors and entered into a convertible
                                            promissory note. The note is secured by collateral of the Company and its subsidiaries. The
                                            note bears interest at 20% per annum, payable monthly, and the principal is due and payable
                                            on April 27, 2030. Per the original terms of the agreement, the note was convertible into
                                            common stock at a conversion price of $0.01257 per share, which was amended on November 9,
                                            2020, to reduce the conversion price to $0.007 per share. At inception we recorded a beneficial
                                            conversion feature and debt discount of $1,300,000. During the six months ended June 30,
                                            2025, we recognized $64,430 of the debt discount into interest expense, and expensed
                                            an additional $130,008 of interest expense on the note, all of which was repaid during the
                                            period.

    18

INVESTVIEW,
INC.

NOTES
TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

AS
OF JUNE 30, 2025

(Unaudited)

[2]On
                                            May 27, 2020, we received proceeds of $700,000 from DBR Capital, LLC, an entity controlled
                                            by a member of our Board of Directors and entered into a convertible promissory note. The
                                            note is secured by collateral of the Company and its subsidiaries. The note bears interest
                                            at 20% per annum, payable monthly, and the principal is due and payable on April 27, 2030.
                                            Per the original terms of the agreement, the note was convertible into common stock at a
                                            conversion price of $0.01257 per share, which was amended on November 9, 2020, to reduce
                                            the conversion price to $0.007 per share. At inception we recorded a beneficial conversion
                                            feature and debt discount of $700,000. During the six months ended June 30, 2025, we recognized
                                            $34,975 of the debt discount into interest expense and expensed an additional $70,002
                                            of interest expense on the note, all